Hutchinson S, et al. Rimegepant 75 mg demonstrates safety and tolerability similar to placebo: results from 3 phase 3 trials in adults with migraine. Abstract IHC-PO-133. IHC 2019 5-8 sept. Dublin, Ierland.
Verstoorde balans tussen hersennetwerken bij mensen met MS met cognitieve problemen
feb 2017 | Multipele Sclerose